New Key Statistics Module, Z-Score and F-Score
NAS:MRNS Key Ratios
| Market Cap $ M | 65.92 |
| Enterprise Value $ M | 28.03 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 2.33 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 28.00 |
| EPS (TTM) $ | -2.64 |
| Beneish M-Score | -3.94 |
| 10-y EBITDA Growth Rate % | 16.90 |
| 5-y EBITDA Growth Rate % | 29.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.22 |
| EV-to-EBITDA | -0.22 |
| PEG | -- |
| Shares Outstanding M | 54.93 |
| Net Margin (%) | -513.80 |
| Operating Margin % | -474.91 |
| Pre-tax Margin (%) | -519.24 |
| Quick Ratio | 2.93 |
| Current Ratio | 3.07 |
| ROA % (ttm) | -77.55 |
| ROE % (ttm) | -368.35 |
| ROIC % (ttm) | -851.62 |
| Dividend Yield % | -- |
| Altman Z-Score | -8.11 |
MRNS Number of Guru Trades
MRNS Volume of Guru Trades
Gurus Latest Trades with NAS:MRNS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MRNS is held by these investors
Total 1
Marinus Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:MRNS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers